| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SCMH1_0012500 | Intron-Intron | chr1:41623483-41623696 | chr1:41157811-41158024 | 214 nt | 0.3131 |
| hsa_SCMH1_0012600 | Exon-Exon | chr1:41625397-41651922 | chr1:41159725-41186250 | 432 nt | 0.3704 |
| hsa_SCMH1_0012700 | Intron-Exon-Intron | chr1:41625397-41660071 | chr1:41159725-41194399 | 233 nt | 0.3391 |
| hsa_SCMH1_0012800 | Exon-Exon | chr1:41626547-41651922 | chr1:41160875-41186250 | 223 nt | 0.4170 |
| hsa_SCMH1_0012900 | Intron-Exon-Intron | chr1:41626547-41668919 | chr1:41160875-41203247 | 24 nt | 0.5000 |
| hsa_SCMH1_0013000 | Intron-Exon-Intron | chr1:41626547-41691745 | chr1:41160875-41226073 | 178 nt | 0.4157 |
| hsa_chr1_0871700 | Intergenic-Intergenic | chr1:41627064-41627961 | chr1:41161392-41162289 | 898 nt | 0.4521 |
| hsa_SCMH1_0013100 | Intron-Intron | chr1:41629701-41630686 | chr1:41164029-41165014 | 986 nt | 0.3550 |
| hsa_SCMH1_0013200 | Intron-Intron | chr1:41629719-41629878 | chr1:41164047-41164206 | 160 nt | 0.3938 |
| hsa_SCMH1_0013300 | Intron-Intron | chr1:41636315-41636461 | chr1:41170643-41170789 | 147 nt | 0.3946 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].